1. Home
  2. FEMY vs FGL Comparison

FEMY vs FGL Comparison

Compare FEMY & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • FGL
  • Stock Information
  • Founded
  • FEMY 2004
  • FGL 2021
  • Country
  • FEMY United States
  • FGL Malaysia
  • Employees
  • FEMY N/A
  • FGL N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • FGL
  • Sector
  • FEMY Health Care
  • FGL
  • Exchange
  • FEMY Nasdaq
  • FGL NYSE
  • Market Cap
  • FEMY 29.9M
  • FGL 25.4M
  • IPO Year
  • FEMY 2021
  • FGL 2024
  • Fundamental
  • Price
  • FEMY $0.94
  • FGL $0.94
  • Analyst Decision
  • FEMY Strong Buy
  • FGL
  • Analyst Count
  • FEMY 3
  • FGL 0
  • Target Price
  • FEMY $8.67
  • FGL N/A
  • AVG Volume (30 Days)
  • FEMY 259.3K
  • FGL 284.8K
  • Earning Date
  • FEMY 08-07-2025
  • FGL 07-22-2025
  • Dividend Yield
  • FEMY N/A
  • FGL N/A
  • EPS Growth
  • FEMY N/A
  • FGL N/A
  • EPS
  • FEMY N/A
  • FGL N/A
  • Revenue
  • FEMY $1,699,232.00
  • FGL $20,205,441.00
  • Revenue This Year
  • FEMY $283.83
  • FGL N/A
  • Revenue Next Year
  • FEMY $161.03
  • FGL N/A
  • P/E Ratio
  • FEMY N/A
  • FGL N/A
  • Revenue Growth
  • FEMY 61.97
  • FGL N/A
  • 52 Week Low
  • FEMY $0.69
  • FGL $0.66
  • 52 Week High
  • FEMY $1.80
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 50.13
  • FGL N/A
  • Support Level
  • FEMY $0.91
  • FGL N/A
  • Resistance Level
  • FEMY $0.99
  • FGL N/A
  • Average True Range (ATR)
  • FEMY 0.05
  • FGL 0.00
  • MACD
  • FEMY 0.00
  • FGL 0.00
  • Stochastic Oscillator
  • FEMY 28.50
  • FGL 0.00

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About FGL FOUNDER GROUP LTD

Founder Group Ltd is a solar solutions provider in Malaysia, offering end-to-end services for commercial and industrial sectors, as well as large-scale solar power projects, encompassing project design, engineering, and comprehensive project management. Its focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects are utility scale solar PV power plants with installed generating capacity of 1 MWac or more. C&I projects are smaller scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their own consumption, such as factories, warehouses and commercial stores. Its revenue is derived from Malaysia.

Share on Social Networks: